Development of Alveolar Hemorrhage After Pfizer-BioNTech COVID-19 mRNA Vaccination in a Patient With Renal-Limited Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report

Since the coronavirus disease 2019 (COVID-19) pandemic continues and a new variant of the virus has emerged, the COVID-19 vaccination campaign has progressed. Rare but severe adverse outcomes of COVID-19 vaccination such as anaphylaxis and myocarditis have begun to be noticed. Of note, several cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishioka, Ken, Yamaguchi, Shintaro, Yasuda, Itaru, Yoshimoto, Norifumi, Kojima, Daiki, Kaneko, Kenji, Aso, Mitsuhiro, Nagasaka, Tomoki, Yoshida, Eriko, Uchiyama, Kiyotaka, Tajima, Takaya, Yoshino, Jun, Yoshida, Tadashi, Kanda, Takeshi, Itoh, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023855/
https://www.ncbi.nlm.nih.gov/pubmed/35462990
http://dx.doi.org/10.3389/fmed.2022.874831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023855/
https://www.ncbi.nlm.nih.gov/pubmed/35462990
http://dx.doi.org/10.3389/fmed.2022.874831

Ejemplares similares